124 related articles for article (PubMed ID: 38072470)
41. Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial.
Fujisawa D; Umemura S; Okizaki A; Satomi E; Yamaguchi T; Miyaji T; Mashiko T; Kobayashi N; Kinoshita H; Mori M; Morita T; Uchitomi Y; Goto K; Ohe Y; Matsumoto Y
BMJ Open; 2020 Nov; 10(11):e037759. PubMed ID: 33243791
[TBL] [Abstract][Full Text] [Related]
42. Using patient-reported outcomes to manage postoperative symptoms in patients with lung cancer: protocol for a multicentre, randomised controlled trial.
Dai W; Zhang Y; Feng W; Liao X; Mu Y; Zhang R; Wei X; Wu C; Xie S; Li Q; Shi Q
BMJ Open; 2019 Aug; 9(8):e030041. PubMed ID: 31455710
[TBL] [Abstract][Full Text] [Related]
43. Efficiency and effectiveness of intensive multidisciplinary follow-up of patients with stroke/TIA or myocardial infarction compared to usual monitoring: protocol of a pragmatic randomised clinical trial. DiVa (Dijon vascular) study.
Béjot Y; Soilly AL; Bardou M; Duloquin G; Pommier T; Laurent G; Cottin Y; Vadot L; Adam H; Boulin M; Giroud M
BMJ Open; 2023 Apr; 13(4):e070197. PubMed ID: 37185649
[TBL] [Abstract][Full Text] [Related]
44. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
45. Protocol for a multicentre, parallel-arm, 12-month, randomised, controlled trial of arthroscopic surgery versus conservative care for femoroacetabular impingement syndrome (FASHIoN).
Griffin DR; Dickenson EJ; Wall PD; Donovan JL; Foster NE; Hutchinson CE; Parsons N; Petrou S; Realpe A; Achten J; Achana F; Adams A; Costa ML; Griffin J; Hobson R; Smith J;
BMJ Open; 2016 Aug; 6(8):e012453. PubMed ID: 27580837
[TBL] [Abstract][Full Text] [Related]
46. Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial).
Taylor S; Yorke J; Tsim S; Navani N; Baldwin D; Woolhouse I; Edwards J; Grundy S; Robson J; Rhodes S; Gomes F; Blackhall F; Faivre-Finn C; Evison M
BMJ Open Respir Res; 2021 Jul; 8(1):. PubMed ID: 34266853
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of carbon dioxide insufflation for brain protection for patients undergoing planned left-sided open heart valve surgery: protocol for a multicentre, placebo-controlled, blinded, randomised controlled trial (the CO2 Study).
Todd R; Rogers CA; Pufulete M; Culliford L; Pretorius P; Voets N; Akowuah E; Sayeed R; Lazaroo M; Kaur S; Angelini GD; Gibbison B
BMJ Open; 2023 May; 13(5):e074221. PubMed ID: 37197819
[TBL] [Abstract][Full Text] [Related]
48. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
49. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
50. Acceptance and Commitment Therapy for Muscle Disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases.
Rose MR; Norton S; Vari C; Edwards V; McCracken L; Graham CD; Radunovic A; Chalder T
BMJ Open; 2018 Oct; 8(10):e022083. PubMed ID: 30287669
[TBL] [Abstract][Full Text] [Related]
51. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
[TBL] [Abstract][Full Text] [Related]
52. UK robotic arthroplasty clinical and cost effectiveness randomised controlled trial for hips (RACER-Hip): a study protocol.
Griffin J; Davis ET; Parsons H; Stevens S; Bradley H; Bruce J; Ellard DR; Haddad F; Hutchinson CE; Mason J; Nwankwo H; Metcalfe A; Smith T; Smith J; Warwick J; Skinner JA; Rees S; Underwood M; Khatri C; Wall PDH
BMJ Open; 2023 Oct; 13(10):e079328. PubMed ID: 37852762
[TBL] [Abstract][Full Text] [Related]
53. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
54. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
Vergis N; Phillips R; Cornelius V; Katsarou A; Youngstein T; Cook L; Willicombe M; Pilay C; Shturova T; Almonte M; Charania A; Turner R; Kon OM; Cooke G; Thursz M; Cherlin S; Wason J; Milojkovic D; Innes AJ; Cooper N
Trials; 2021 Apr; 22(1):270. PubMed ID: 33845867
[TBL] [Abstract][Full Text] [Related]
55. Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo)radiotherapy: Additional contact X-ray brachytherapy versus eXtending the observation period and local excision (OPAXX) - protocol for two multicentre, parallel, single-arm, phase II studies.
Geubels BM; van Triest B; Peters FP; Maas M; Beets GL; Marijnen CAM; Custers PA; Rutten HJT; Theuws JCM; Verrijssen AE; Cnossen JS; Burger JWA; Grotenhuis BA
BMJ Open; 2023 Dec; 13(12):e076866. PubMed ID: 38159950
[TBL] [Abstract][Full Text] [Related]
56. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
57. Total ankle replacement versus ankle arthrodesis for patients aged 50-85 years with end-stage ankle osteoarthritis: the TARVA RCT.
Goldberg AJ; Chowdhury K; Bordea E; Blackstone J; Brooking D; Deane EL; Hauptmannova I; Cooke P; Cumbers M; Skene SS; Doré CJ
Health Technol Assess; 2023 Mar; 27(5):1-80. PubMed ID: 37022932
[TBL] [Abstract][Full Text] [Related]
58. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
[TBL] [Abstract][Full Text] [Related]
59. The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.
Zeng Y; Ni J; Yu F; Zhou Y; Zhao Y; Li S; Guo T; Chu L; Yang X; Chu X; Cai X; Zhu Z
Radiat Oncol; 2020 Aug; 15(1):207. PubMed ID: 32854745
[TBL] [Abstract][Full Text] [Related]
60. Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).
Pang K; Yang Y; Tian D; Zeng N; Cao S; Ling S; Gao J; Zhao P; Wang H; Kong Y; Zhang J; Chen G; Deng W; Bai Z; Jin L; Wu G; Zhu D; Wang Y; Zhou J; Wu B; Lin G; Xiao Y; Gao Z; Ye Y; Wang X; Li A; Han J; Yao H; Yang Y; Zhang Z
BMJ Open; 2023 Sep; 13(9):e069499. PubMed ID: 37699634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
